Plan your Thursday schedule and don’t miss notable items on the program, including the second General Session, the Molecular Tumor Board session, and presentations on artificial intelligence.

Claudine Isaacs, MD, will lead a Thursday afternoon panel discussion on the future of cancer genetics in the field of risk reduction and early detection of breast cancer.

Monica Morrow, MD, will moderate a session looking at evolving practices around axillary staging in estrogen receptor-positive breast cancer and implications on adjuvant therapies.

Heather McArthur, MD, MPH, will guide a Thursday afternoon panel discussion about how immunotherapy may expand its reach and the tools physicians can use to make therapeutic selections.

Paolo Tarantino, MD, will moderate a People’s Choice educational session on future directions in antibody-drug conjugates on Wednesday afternoon.

Plan your Wednesday schedule and don’t miss notable items on the program, including the first General Session, the keynote address from a Nobel Prize winner, and the 2024 William L. McGuire Memorial Lecture.

Christina Curtis, PhD, MSc, left, and Steffi Oesterreich, PhD, will be recognized by the American Association for Cancer Research (AACR) for significant contributions to breast cancer research.

Sherene Loi, MBBS (Hons), PhD, FRACP, FAHMS, GAICD, will lead a panel discussion on Wednesday afternoon about the winding road of immune biomarkers in early breast cancer.

Ismail Jatoi, MD, PhD, will moderate a Wednesday afternoon risk reduction and early detection session on updates in breast cancer screening.

Antonio Wolff, MD, will moderate a Wednesday afternoon session on questions that will inform clinical trial design and guide treatment decisions.